No abstract available
MeSH terms
-
Clinical Trials as Topic*
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
DNA*
-
DNA, Recombinant
-
Genetic Therapy* / adverse effects
-
HLA-B7 Antigen / biosynthesis
-
HLA-B7 Antigen / genetics
-
Humans
-
Lipids / adverse effects
-
Lipids / pharmacokinetics
-
Lipids / therapeutic use*
-
Multicenter Studies as Topic*
-
Neoplasms / therapy*
-
Plasmids / adverse effects
-
Plasmids / genetics
-
Plasmids / pharmacokinetics
-
Plasmids / therapeutic use*
-
beta 2-Microglobulin / biosynthesis
-
beta 2-Microglobulin / genetics
Substances
-
Allovectin-7
-
DNA, Recombinant
-
HLA-B7 Antigen
-
Lipids
-
beta 2-Microglobulin
-
DNA